Tong Du
Impact in
-
- Myasthenia Gravis and Thymoma
- Peripheral Neuropathies and Disorders
- Neuroinflammation and Neurodegeneration Mechanisms
-
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
Papers in
-
- Myasthenia Gravis and Thymoma 6
- Peripheral Neuropathies and Disorders 5
- Neuroinflammation and Neurodegeneration Mechanisms 2
-
- Antifungal resistance and susceptibility 3
- Co-authors
- Chunlin Yang (17 shared papers)Rui‐Sheng Duan (16 shared papers)Heng Li (10 shared papers)Yudong Liu (7 shared papers)Ying‐Chun Dou (5 shared papers)Xiaoli Li (5 shared papers)Peng Zhang (2 shared papers)Min Zhang (4 shared papers)
In The Last Decade
Tong Du
18 papers receiving 283 citations
Peers
Comparison fields: 5 of 70
- Neurology 59
- Immunology 77
- Neurology 24
- Biological Psychiatry 6
- Cancer Research 33
Countries citing papers authored by Tong Du
This map shows the geographic impact of Tong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tong Du more than expected).
Fields of papers citing papers by Tong Du
This network shows the impact of papers produced by Tong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tong Du. The network helps show where Tong Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Tong Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 65 | |
| 2 | 2018 | 50 | |
| 3 | 2019 | 18 | |
| 4 | 2021 | 17 | |
| 5 | 2023 | 16 | |
| 6 | 2024 | 16 | |
| 7 | 2021 | 15 | |
| 8 | 2019 | 15 | |
| 9 | 2021 | 15 | |
| 10 | 2023 | 14 | |
| 11 | 2021 | 11 | |
| 12 | 2023 | 8 | |
| 13 | 2018 | 7 | |
| 14 | 2023 | 6 | |
| 15 | 2022 | 5 | |
| 16 | 2024 | 3 | |
| 17 | 2024 | 2 | |
| 18 | 2025 | 1 | |
| 19 | 2025 | 0 |
About Tong Du
Tong Du is a scholar working on Neurology, Infectious Diseases, Molecular Biology, Immunology and Neurology, having authored 19 papers that have together received 284 indexed citations. Recurring topics across this work include Myasthenia Gravis and Thymoma (6 papers), Peripheral Neuropathies and Disorders (5 papers), Antifungal resistance and susceptibility (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Extracellular vesicles in disease (2 papers), Alzheimer's disease research and treatments (1 paper), Endometriosis Research and Treatment (1 paper) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). The work is most often cited by research in Neurology (59 citations), Immunology (77 citations), Neurology (24 citations), Biological Psychiatry (6 citations) and Cancer Research (33 citations). Tong Du has collaborated with scholars based in China, Slovakia and Japan. Frequent co-authors include Chunlin Yang, Rui‐Sheng Duan, Heng Li, Yudong Liu, Ying‐Chun Dou, Xiaoli Li, Peng Zhang, Min Zhang, Tao Li and Ying Liu. Their work appears in journals such as Journal of Neuroinflammation, Biochemical and Biophysical Research Communications, Journal of Neuroimmunology, Neurochemical Research and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.